NCT04704323
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04704323
Title CAP-100 for Subjects With Relapsed/Refractory Chronic Lymphocytic Leukemia
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Catapult Therapeutics
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | ESP

Facility Status City State Zip Country Details
Dana-Farber Cancer Institute RECRUITING Boston Massachusetts 02215 United States Details
Duke University RECRUITING Durham North Carolina 27705 United States Details
Hospital Universitario de La Princesa RECRUITING Madrid 28006 Spain Details
Hospital Universitario Marqués de Valdecilla RECRUITING Santander 39008 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field